Denmark‘s economy is heading for slower growth as the pharmaceutical boom led by Novo Nordisk A/S loses steam and the industry settles into a pace more in line with the rest of the economy, the country’s financial watchdog said.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.